Incyte and AstraZeneca to Enter Clinical Trial Collaboration in Early Lung Cancer
Go back to Incyte and AstraZeneca to Enter Clinical Trial Collaboration in Early Lung Cancer| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,937,806 | |||||
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 124.65 -0.66 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.31 | 52 Week High | $118.49 | |||
| Open | $125.00 | 52 Week Low | $55.00 | |||
| Day High | $127.41 | P/E | N/A | |||
| Day Low | $124.19 | EPS | $-0.56 | |||
| Volume | 1,270,532 | |||||
